CELZ: Creative Medical Technology Holdings Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Creative Medical Technology Holdings Inc (CELZ).

OverviewDividends

$4.04M Market Cap.

As of 05/11/2025 5:00 PM ET (MRY) • Disclaimer

CELZ Market Cap. (MRY)


CELZ Shares Outstanding (MRY)


CELZ Assets (MRY)


Total Assets

$6.67M

Total Liabilities

$327.64K

Total Investments

$0

CELZ Income (MRY)


Revenue

$11.00K

Net Income

-$5.49M

Operating Expense

$5.75M

CELZ Cash Flow (MRY)


CF Operations

-$5.30M

CF Investing

$6.32M

CF Financing

$1.45M

CELZ Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$6,669,143 (-37.76%)

$10,715,190 (-44.15%)

$19,186,326 (70.27%)

$11,268,181 (1469.88%)

Assets Current

$6,135,303 (-40.27%)

$10,270,898 (-45.21%)

$18,747,450 (74.60%)

$10,737,221 (10855.01%)

Assets Non-Current

$533,840 (20.16%)

$444,292 (1.23%)

$438,876 (-17.34%)

$530,960 (-14.33%)

Goodwill & Intangible Assets

$530,559 (20.31%)

$441,011 (1.24%)

$435,595 (-17.45%)

$527,679 (-14.86%)

Shareholders Equity

$6,341,499 (-38.69%)

$10,343,796 (-34.80%)

$15,864,674 (55.27%)

$10,217,740 (125.67%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$5,940,402 (71.35%)

$3,466,867 (-58.33%)

$8,320,519 (-22.41%)

$10,723,870 (10841.38%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$6,520,191 (-35.31%)

$10,078,617 (0%)

$0 (0%)

Investments Current

$0 (0%)

$6,520,191 (-35.31%)

$10,078,617 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,194 (-66.73%)

$6,594 (-35.31%)

$10,194 (-6.18%)

$10,866 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$2,485 (0%)

Trade & Non-Trade Payables

$273,530 (-13.79%)

$317,280 (-90.29%)

$3,267,538 (222.92%)

$1,011,862 (23.45%)

Accumulated Retained Earnings (Deficit)

-$64,591,913 (-9.30%)

-$59,098,432 (-9.82%)

-$53,811,858 (-23.23%)

-$43,667,814 (29.44%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$14,194 (0.00%)

$14,194 (0.00%)

$14,194 (0.00%)

$14,194 (-98.22%)

Debt Current

$14,194 (0.00%)

$14,194 (0.00%)

$14,194 (0.00%)

$14,194 (-98.22%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$327,644 (-11.78%)

$371,394 (-88.82%)

$3,321,652 (216.21%)

$1,050,441 (-97.41%)

Liabilities Current

$327,644 (-11.78%)

$371,394 (-88.82%)

$3,321,652 (216.21%)

$1,050,441 (-97.41%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

CELZ Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$11,000 (22.22%)

$9,000 (-89.84%)

$88,600 (0.96%)

$87,754 (-46.65%)

Cost of Revenue

$4,400 (22.22%)

$3,600 (-87.36%)

$28,491 (-40.58%)

$47,949 (-5.23%)

Selling General & Administrative Expense

$3,239,232 (-9.02%)

$3,560,309 (-9.72%)

$3,943,543 (33.03%)

$2,964,490 (155.13%)

Research & Development Expense

$2,400,777 (21.83%)

$1,970,639 (-68.56%)

$6,268,854 (5641.76%)

$109,180 (0%)

Operating Expenses

$5,750,461 (2.22%)

$5,625,532 (-45.41%)

$10,304,481 (225.50%)

$3,165,754 (157.64%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$4,278,433 (247.96%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$5,493,481 (-3.91%)

-$5,286,574 (47.88%)

-$10,144,044 (-152.80%)

$19,211,768 (152.89%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$5,493,481 (-3.91%)

-$5,286,574 (47.88%)

-$10,144,044 (-152.80%)

$19,211,768 (152.89%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$5,493,481 (-3.91%)

-$5,286,574 (47.88%)

-$10,144,044 (-152.80%)

$19,211,768 (152.89%)

Weighted Average Shares

$1,480,420 (5.17%)

$1,407,632 (28.76%)

$1,093,204 (319.65%)

$260,506 (349.57%)

Weighted Average Shares Diluted

$1,480,420 (5.17%)

$1,407,632 (28.76%)

$1,093,204 (236.51%)

$324,862 (460.63%)

Earning Before Interest & Taxes (EBIT)

-$5,493,481 (-3.91%)

-$5,286,574 (47.88%)

-$10,144,044 (-143.18%)

$23,490,201 (166.93%)

Gross Profit

$6,600 (22.22%)

$5,400 (-91.02%)

$60,109 (51.01%)

$39,805 (-65.05%)

Operating Income

-$5,743,861 (-2.20%)

-$5,620,132 (45.14%)

-$10,244,372 (-227.72%)

-$3,125,949 (-180.40%)

CELZ Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$6,320,191 (83.45%)

$3,445,185 (134.18%)

-$10,078,617 (0%)

$0 (0%)

Net Cash Flow from Financing

$1,454,636 (636.86%)

-$270,952 (-101.75%)

$15,472,232 (20.48%)

$12,841,640 (1750.59%)

Net Cash Flow from Operations

-$5,301,292 (33.96%)

-$8,027,885 (-2.96%)

-$7,796,966 (-251.88%)

-$2,215,782 (-409.90%)

Net Cash Flow / Change in Cash & Cash Equivalents

$2,473,535 (150.96%)

-$4,853,652 (-101.95%)

-$2,403,351 (-122.62%)

$10,625,858 (113375.63%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$6,520,191 (83.92%)

$3,545,185 (135.18%)

-$10,078,617 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$2,073,636 (-398.83%)

Issuance (Purchase) of Equity Shares

$1,454,536 (636.82%)

-$270,952 (-101.75%)

$15,472,232 (4.84%)

$14,758,488 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$36,648 (0.00%)

$36,648 (-46.69%)

$68,746 (-88.45%)

$595,380 (249.56%)

Depreciation Amortization & Accretion

$110,452 (16.78%)

$94,584 (2.71%)

$92,084 (0.00%)

$92,084 (37.87%)

CELZ Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

60.00% (0.00%)

60.00% (-11.50%)

67.80% (49.34%)

45.40% (-34.39%)

Profit Margin

-49940.70% (14.98%)

-58739.70% (-413.04%)

-11449.30% (-152.30%)

21892.80% (199.14%)

EBITDA Margin

-48936.60% (15.17%)

-57688.80% (-408.48%)

-11345.30% (-142.22%)

26873.20% (226.20%)

Return on Average Equity (ROAE)

-73.90% (-78.07%)

-41.50% (28.08%)

-57.70% (-105.03%)

1147.40% (294.57%)

Return on Average Assets (ROAA)

-70.50% (-75.37%)

-40.20% (25.83%)

-54.20% (-111.29%)

480.20% (106.79%)

Return on Sales (ROS)

-49940.70% (14.98%)

-58739.70% (-413.04%)

-11449.30% (-142.77%)

26768.20% (225.47%)

Return on Invested Capital (ROIC)

2890.00% (887.90%)

-366.80% (44.05%)

-655.60% (61.68%)

-1710.70% (-687.26%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.62 (49.18%)

-1.23 (-198.30%)

-0.41 (-237.00%)

0.3 (235.14%)

Price to Sales Ratio (P/S)

310.89 (-56.88%)

721.02 (1433.33%)

47.02 (-28.33%)

65.61 (33.99%)

Price to Book Ratio (P/B)

0.64 (3.41%)

0.62 (82.25%)

0.34 (-78.58%)

1.58 (491.56%)

Debt to Equity Ratio (D/E)

0.05 (44.44%)

0.04 (-82.78%)

0.21 (102.91%)

0.1 (110.12%)

Earnings Per Share (EPS)

-3.71 (1.33%)

-3.76 (59.48%)

-9.28 (-112.59%)

73.7 (111.76%)

Sales Per Share (SPS)

0.01 (16.67%)

0.01 (-92.59%)

0.08 (-75.96%)

0.34 (-88.13%)

Free Cash Flow Per Share (FCFPS)

-3.58 (37.21%)

-5.7 (20.04%)

-7.13 (16.15%)

-8.51 (-13.43%)

Book Value Per Share (BVPS)

4.28 (-41.70%)

7.35 (-49.37%)

14.51 (-63.00%)

39.22 (105.71%)

Tangible Assets Book Value Per Share (TABVPS)

4.15 (-43.18%)

7.3 (-57.45%)

17.15 (-58.40%)

41.23 (2338.14%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

1 (-50.00%)

2 (100.00%)

1 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.41 (-61.90%)

1.08 (-34.91%)

1.65 (136.14%)

0.7 (244.93%)

Asset Turnover

0 (0.00%)

0 (-80.00%)

0.01 (-77.27%)

0.02 (-93.12%)

Current Ratio

18.73 (-32.29%)

27.66 (389.99%)

5.64 (-44.79%)

10.22 (511000.00%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$5,301,292 (33.96%)

-$8,027,885 (-2.96%)

-$7,796,966 (-251.88%)

-$2,215,782 (-409.90%)

Enterprise Value (EV)

-$2,207,375 (60.50%)

-$5,588,659 (66.36%)

-$16,611,719 (-200.65%)

$16,504,668 (-2.48%)

Earnings Before Tax (EBT)

-$5,493,481 (-3.91%)

-$5,286,574 (47.88%)

-$10,144,044 (-152.80%)

$19,211,768 (152.89%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$5,383,029 (-3.68%)

-$5,191,990 (48.35%)

-$10,051,960 (-142.63%)

$23,582,285 (167.32%)

Invested Capital

-$115,268 (-101.79%)

$6,450,112 (-9.44%)

$7,122,754 (798.57%)

-$1,019,615 (97.43%)

Working Capital

$5,807,659 (-41.33%)

$9,899,504 (-35.83%)

$15,425,798 (59.25%)

$9,686,780 (123.96%)

Tangible Asset Value

$6,138,584 (-40.25%)

$10,274,179 (-45.21%)

$18,750,731 (74.58%)

$10,740,502 (10858.35%)

Market Capitalization

$4,038,869 (-36.61%)

$6,371,601 (18.77%)

$5,364,457 (-66.73%)

$16,121,868 (0.48%)

Average Equity

$7,435,140 (-41.67%)

$12,746,760 (-27.51%)

$17,583,620 (950.18%)

$1,674,342 (113.40%)

Average Assets

$7,791,586 (-40.73%)

$13,146,414 (-29.72%)

$18,705,669 (367.52%)

$4,001,070 (678.70%)

Invested Capital Average

-$190,086 (-113.19%)

$1,441,143 (-6.86%)

$1,547,305 (212.69%)

-$1,373,120 (88.60%)

Shares

1,748,428 (26.50%)

1,382,126 (-1.81%)

1,407,625 (92.96%)

729,496 (532.00%)